Zentek (CVE:ZEN) Shares Down 15.6% - Time to Sell?

Zentek Ltd. (CVE:ZEN - Get Free Report) fell 15.6% on Monday . The company traded as low as C$1.08 and last traded at C$1.24. 334,625 shares changed hands during mid-day trading, an increase of 652% from the average session volume of 44,495 shares. The stock had previously closed at C$1.47.

Zentek Stock Down 2.5%

The company has a debt-to-equity ratio of 4.97, a quick ratio of 7.59 and a current ratio of 2.06. The company has a market capitalization of C$122.25 million, a price-to-earnings ratio of -11.23 and a beta of 0.77. The stock's fifty day simple moving average is C$1.87 and its two-hundred day simple moving average is C$1.67.

Insider Activity at Zentek

In other Zentek news, Senior Officer Colin Stuart Van Der Kuur sold 15,000 shares of the firm's stock in a transaction dated Thursday, May 8th. The shares were sold at an average price of C$2.20, for a total value of C$33,000.00. 6.01% of the stock is currently owned by insiders.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.